{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 404,
   "id": "3893acb0",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 405,
   "id": "cba6c182",
   "metadata": {},
   "outputs": [],
   "source": [
    "data = pd.read_pickle(\"breast_cancer.pkl\")\n",
    "pd.options.mode.chained_assignment = None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 406,
   "id": "4e8cf423",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTID</th>\n",
       "      <th>Phase</th>\n",
       "      <th>Status</th>\n",
       "      <th>Allocation</th>\n",
       "      <th>Intervention_Model</th>\n",
       "      <th>Intervention</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Criteria</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>ArmsNumber</th>\n",
       "      <th>...</th>\n",
       "      <th>Mesh_Term</th>\n",
       "      <th>Inclusion_Criteria</th>\n",
       "      <th>Exclusion_Criteria</th>\n",
       "      <th>Inclusion_Ent</th>\n",
       "      <th>Exclusion_Ent</th>\n",
       "      <th>Intervention_Ent</th>\n",
       "      <th>Conditions_Ent</th>\n",
       "      <th>Mesh_Term_Ent</th>\n",
       "      <th>Select Disease</th>\n",
       "      <th>Select Mesh</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01304251</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Other: Short-term fasting , Other: Healthy nut...</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>13</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>inclusion criteria . female breast cancer pati...</td>\n",
       "      <td>. serious other diseases such as recent myocar...</td>\n",
       "      <td>{(breast cancer, DISEASE), (creatinine, CHEMIC...</td>\n",
       "      <td>{(myocardial infarction, DISEASE), (cardiac fa...</td>\n",
       "      <td>{}</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT01303679</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Drug: Paclitaxel , Drug: Bevacizumab , Drug: E...</td>\n",
       "      <td>First Line Metastatic Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>117</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>inclusion criteria . age 18 ans. . metastatic ...</td>\n",
       "      <td>. previous treatment by exemestane . . 1st lin...</td>\n",
       "      <td>{(breast cancer, DISEASE)}</td>\n",
       "      <td>{(coagulopathy, DISEASE), (thrombosis, DISEASE...</td>\n",
       "      <td>{(Exemestane, CHEMICAL), (Paclitaxel, CHEMICAL)}</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT01300962</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>Drug: BMK120 , Drug: Capecitabine , Drug: BYL7...</td>\n",
       "      <td>Metastatic Breast Cancer</td>\n",
       "      <td>\\n        PATIENT ELIGIBILITY Inclusion Criter...</td>\n",
       "      <td>47</td>\n",
       "      <td>4</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>patient eligibility inclusion criteria . age 1...</td>\n",
       "      <td>subjects meeting any of the exclusion criteria...</td>\n",
       "      <td>{(recist, DISEASE), (magnesium, CHEMICAL), (gl...</td>\n",
       "      <td>{(allergic reactions, DISEASE), (schizophrenia...</td>\n",
       "      <td>{(Lapatinib, CHEMICAL), (BYL719, CHEMICAL), (C...</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01306188</td>\n",
       "      <td>0</td>\n",
       "      <td>Completed</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Biological: Breast cancer cohort , Biological:...</td>\n",
       "      <td>Breast Cancer , Lung Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>179</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>Lung Neoplasms</td>\n",
       "      <td>inclusion criteria . age 18 years old , . pati...</td>\n",
       "      <td>. hematological tumour , . auto.immune disease...</td>\n",
       "      <td>{(breast or lung tumour, DISEASE)}</td>\n",
       "      <td>{(hematological tumour, DISEASE)}</td>\n",
       "      <td>{(Lung cancer, DISEASE), (Breast cancer, DISEA...</td>\n",
       "      <td>{(Breast Cancer, DISEASE), (Lung Cancer, DISEA...</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01301911</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>Drug: Cipatinib ,</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>26</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>inclusion criteria . aged 18 and 65 years. . e...</td>\n",
       "      <td>. subjects with third space fluid that can not...</td>\n",
       "      <td>{(creatinine, CHEMICAL), (breast cancer, DISEA...</td>\n",
       "      <td>{(arrhythmia, DISEASE), (epilepsy, DISEASE), (...</td>\n",
       "      <td>{}</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11389</th>\n",
       "      <td>NCT04612439</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Device: VABB Elite 10G , Device: BARD 14G CNB ,</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>1470</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>inclusion criteria . over 18 years old . ultra...</td>\n",
       "      <td>. a biopsy has been performed in the external ...</td>\n",
       "      <td>{}</td>\n",
       "      <td>{(coagulation dysfunction, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>None</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11390</th>\n",
       "      <td>NCT04616248</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Sequential Assignment</td>\n",
       "      <td>Biological: Anti-CD40 Agonist Monoclonal Antib...</td>\n",
       "      <td>Anatomic Stage IV Breast Cancer AJCC v8 , Meta...</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>18</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>inclusion criteria . have clinically or pathol...</td>\n",
       "      <td>. patients currently treated with systemic imm...</td>\n",
       "      <td>{(alanine, CHEMICAL), (creatinine, CHEMICAL), ...</td>\n",
       "      <td>{(autoimmune disease, DISEASE), (cancer, DISEA...</td>\n",
       "      <td>{(Poly ICLC, CHEMICAL)}</td>\n",
       "      <td>{(Breast Cancer AJCC, DISEASE), (Breast Carcin...</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11391</th>\n",
       "      <td>NCT04617236</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>Behavioral: Cultivando La Salud ,</td>\n",
       "      <td>Breast Cancer , Cervical Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>444</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>Uterine Cervical Neoplasms</td>\n",
       "      <td>inclusion criteria . women aged 21 and older f...</td>\n",
       "      <td>. having completed a papanicolau test in the p...</td>\n",
       "      <td>{}</td>\n",
       "      <td>{(cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>{(Cancer, DISEASE), (Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11392</th>\n",
       "      <td>NCT04619186</td>\n",
       "      <td>0</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td></td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>1694</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>inclusion criteria 1. women over 25 years of a...</td>\n",
       "      <td>1. women with signs or symptoms of breast canc...</td>\n",
       "      <td>{(breast cancer, DISEASE)}</td>\n",
       "      <td>{(breast cancer, DISEASE), (claustrophobia, DI...</td>\n",
       "      <td>{}</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11393</th>\n",
       "      <td>NCT04613674</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Drug: Camrelizumab Plus Chemotherapy , Drug: p...</td>\n",
       "      <td>Triple Negative Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>581</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>inclusion criteria . ecog performance status o...</td>\n",
       "      <td>. has a history of breast cancer. . has a hist...</td>\n",
       "      <td>{(tumor, DISEASE)}</td>\n",
       "      <td>{(breast cancer, DISEASE), (anti.programmed, D...</td>\n",
       "      <td>{}</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>11394 rows × 28 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "             NCTID    Phase                  Status      Allocation   \n",
       "0      NCT01304251      N/A               Completed      Randomized  \\\n",
       "1      NCT01303679  Phase 3              Terminated      Randomized   \n",
       "2      NCT01300962  Phase 1               Completed  Non-Randomized   \n",
       "3      NCT01306188        0               Completed               0   \n",
       "4      NCT01301911  Phase 1              Terminated             N/A   \n",
       "...            ...      ...                     ...             ...   \n",
       "11389  NCT04612439  Phase 3  Active, not recruiting      Randomized   \n",
       "11390  NCT04616248  Phase 1              Recruiting  Non-Randomized   \n",
       "11391  NCT04617236      N/A               Completed      Randomized   \n",
       "11392  NCT04619186        0      Not yet recruiting               0   \n",
       "11393  NCT04613674  Phase 3              Recruiting      Randomized   \n",
       "\n",
       "            Intervention_Model   \n",
       "0          Parallel Assignment  \\\n",
       "1          Parallel Assignment   \n",
       "2      Single Group Assignment   \n",
       "3                            0   \n",
       "4      Single Group Assignment   \n",
       "...                        ...   \n",
       "11389      Parallel Assignment   \n",
       "11390    Sequential Assignment   \n",
       "11391  Single Group Assignment   \n",
       "11392                        0   \n",
       "11393      Parallel Assignment   \n",
       "\n",
       "                                            Intervention   \n",
       "0      Other: Short-term fasting , Other: Healthy nut...  \\\n",
       "1      Drug: Paclitaxel , Drug: Bevacizumab , Drug: E...   \n",
       "2      Drug: BMK120 , Drug: Capecitabine , Drug: BYL7...   \n",
       "3      Biological: Breast cancer cohort , Biological:...   \n",
       "4                                     Drug: Cipatinib ,    \n",
       "...                                                  ...   \n",
       "11389   Device: VABB Elite 10G , Device: BARD 14G CNB ,    \n",
       "11390  Biological: Anti-CD40 Agonist Monoclonal Antib...   \n",
       "11391                 Behavioral: Cultivando La Salud ,    \n",
       "11392                                                      \n",
       "11393  Drug: Camrelizumab Plus Chemotherapy , Drug: p...   \n",
       "\n",
       "                                              Conditions   \n",
       "0                                          Breast Cancer  \\\n",
       "1                    First Line Metastatic Breast Cancer   \n",
       "2                               Metastatic Breast Cancer   \n",
       "3                            Breast Cancer , Lung Cancer   \n",
       "4                                          Breast Cancer   \n",
       "...                                                  ...   \n",
       "11389                                      Breast Cancer   \n",
       "11390  Anatomic Stage IV Breast Cancer AJCC v8 , Meta...   \n",
       "11391                    Breast Cancer , Cervical Cancer   \n",
       "11392                                      Breast Cancer   \n",
       "11393                      Triple Negative Breast Cancer   \n",
       "\n",
       "                                                Criteria Enrollment   \n",
       "0      \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         13  \\\n",
       "1      \\n        Inclusion Criteria:\\r\\n\\r\\n         ...        117   \n",
       "2      \\n        PATIENT ELIGIBILITY Inclusion Criter...         47   \n",
       "3      \\n        Inclusion Criteria:\\r\\n\\r\\n         ...        179   \n",
       "4      \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         26   \n",
       "...                                                  ...        ...   \n",
       "11389  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...       1470   \n",
       "11390  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         18   \n",
       "11391  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...        444   \n",
       "11392  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...       1694   \n",
       "11393  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...        581   \n",
       "\n",
       "      ArmsNumber  ...                   Mesh_Term   \n",
       "0              2  ...            Breast Neoplasms  \\\n",
       "1              2  ...            Breast Neoplasms   \n",
       "2              4  ...            Breast Neoplasms   \n",
       "3              0  ...              Lung Neoplasms   \n",
       "4              1  ...            Breast Neoplasms   \n",
       "...          ...  ...                         ...   \n",
       "11389          2  ...                           0   \n",
       "11390          2  ...                   Carcinoma   \n",
       "11391          2  ...  Uterine Cervical Neoplasms   \n",
       "11392          0  ...            Breast Neoplasms   \n",
       "11393          2  ...            Breast Neoplasms   \n",
       "\n",
       "                                      Inclusion_Criteria   \n",
       "0      inclusion criteria . female breast cancer pati...  \\\n",
       "1      inclusion criteria . age 18 ans. . metastatic ...   \n",
       "2      patient eligibility inclusion criteria . age 1...   \n",
       "3      inclusion criteria . age 18 years old , . pati...   \n",
       "4      inclusion criteria . aged 18 and 65 years. . e...   \n",
       "...                                                  ...   \n",
       "11389  inclusion criteria . over 18 years old . ultra...   \n",
       "11390  inclusion criteria . have clinically or pathol...   \n",
       "11391  inclusion criteria . women aged 21 and older f...   \n",
       "11392  inclusion criteria 1. women over 25 years of a...   \n",
       "11393  inclusion criteria . ecog performance status o...   \n",
       "\n",
       "                                      Exclusion_Criteria   \n",
       "0      . serious other diseases such as recent myocar...  \\\n",
       "1      . previous treatment by exemestane . . 1st lin...   \n",
       "2      subjects meeting any of the exclusion criteria...   \n",
       "3      . hematological tumour , . auto.immune disease...   \n",
       "4      . subjects with third space fluid that can not...   \n",
       "...                                                  ...   \n",
       "11389  . a biopsy has been performed in the external ...   \n",
       "11390  . patients currently treated with systemic imm...   \n",
       "11391  . having completed a papanicolau test in the p...   \n",
       "11392  1. women with signs or symptoms of breast canc...   \n",
       "11393  . has a history of breast cancer. . has a hist...   \n",
       "\n",
       "                                           Inclusion_Ent   \n",
       "0      {(breast cancer, DISEASE), (creatinine, CHEMIC...  \\\n",
       "1                             {(breast cancer, DISEASE)}   \n",
       "2      {(recist, DISEASE), (magnesium, CHEMICAL), (gl...   \n",
       "3                     {(breast or lung tumour, DISEASE)}   \n",
       "4      {(creatinine, CHEMICAL), (breast cancer, DISEA...   \n",
       "...                                                  ...   \n",
       "11389                                                 {}   \n",
       "11390  {(alanine, CHEMICAL), (creatinine, CHEMICAL), ...   \n",
       "11391                                                 {}   \n",
       "11392                         {(breast cancer, DISEASE)}   \n",
       "11393                                 {(tumor, DISEASE)}   \n",
       "\n",
       "                                           Exclusion_Ent   \n",
       "0      {(myocardial infarction, DISEASE), (cardiac fa...  \\\n",
       "1      {(coagulopathy, DISEASE), (thrombosis, DISEASE...   \n",
       "2      {(allergic reactions, DISEASE), (schizophrenia...   \n",
       "3                      {(hematological tumour, DISEASE)}   \n",
       "4      {(arrhythmia, DISEASE), (epilepsy, DISEASE), (...   \n",
       "...                                                  ...   \n",
       "11389               {(coagulation dysfunction, DISEASE)}   \n",
       "11390  {(autoimmune disease, DISEASE), (cancer, DISEA...   \n",
       "11391                                {(cancer, DISEASE)}   \n",
       "11392  {(breast cancer, DISEASE), (claustrophobia, DI...   \n",
       "11393  {(breast cancer, DISEASE), (anti.programmed, D...   \n",
       "\n",
       "                                        Intervention_Ent   \n",
       "0                                                     {}  \\\n",
       "1       {(Exemestane, CHEMICAL), (Paclitaxel, CHEMICAL)}   \n",
       "2      {(Lapatinib, CHEMICAL), (BYL719, CHEMICAL), (C...   \n",
       "3      {(Lung cancer, DISEASE), (Breast cancer, DISEA...   \n",
       "4                                                     {}   \n",
       "...                                                  ...   \n",
       "11389                                                 {}   \n",
       "11390                            {(Poly ICLC, CHEMICAL)}   \n",
       "11391                                                 {}   \n",
       "11392                                                 {}   \n",
       "11393                                                 {}   \n",
       "\n",
       "                                          Conditions_Ent Mesh_Term_Ent   \n",
       "0                             {(Breast Cancer, DISEASE)}            {}  \\\n",
       "1                             {(Breast Cancer, DISEASE)}            {}   \n",
       "2                             {(Breast Cancer, DISEASE)}            {}   \n",
       "3      {(Breast Cancer, DISEASE), (Lung Cancer, DISEA...            {}   \n",
       "4                             {(Breast Cancer, DISEASE)}            {}   \n",
       "...                                                  ...           ...   \n",
       "11389                         {(Breast Cancer, DISEASE)}          None   \n",
       "11390  {(Breast Cancer AJCC, DISEASE), (Breast Carcin...            {}   \n",
       "11391      {(Cancer, DISEASE), (Breast Cancer, DISEASE)}            {}   \n",
       "11392                         {(Breast Cancer, DISEASE)}            {}   \n",
       "11393                         {(Breast Cancer, DISEASE)}            {}   \n",
       "\n",
       "      Select Disease Select Mesh  \n",
       "0               True        True  \n",
       "1               True        True  \n",
       "2               True        True  \n",
       "3               True       False  \n",
       "4               True        True  \n",
       "...              ...         ...  \n",
       "11389           True       False  \n",
       "11390           True       False  \n",
       "11391           True       False  \n",
       "11392           True        True  \n",
       "11393           True        True  \n",
       "\n",
       "[11394 rows x 28 columns]"
      ]
     },
     "execution_count": 406,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9d95baf8",
   "metadata": {},
   "source": [
    "# Intervention"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 407,
   "id": "126ef6ec",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{('Exemestane', 'CHEMICAL'), ('Tamoxifen', 'CHEMICAL')}"
      ]
     },
     "execution_count": 407,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data['Intervention_Ent'][71]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 408,
   "id": "3724e7e1",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_drugName(text:set):\n",
    "    first_values = [pair[0] for pair in text]\n",
    "    return first_values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 409,
   "id": "3561636c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0                                       []\n",
       "1                 [Exemestane, Paclitaxel]\n",
       "2        [Lapatinib, BYL719, Capecitabine]\n",
       "3             [Lung cancer, Breast cancer]\n",
       "4                                       []\n",
       "                       ...                \n",
       "11389                                   []\n",
       "11390                          [Poly ICLC]\n",
       "11391                                   []\n",
       "11392                                   []\n",
       "11393                                   []\n",
       "Name: Intervention_Ent, Length: 11394, dtype: object"
      ]
     },
     "execution_count": 409,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data['Intervention_Ent'] = data['Intervention_Ent'].apply(get_drugName)\n",
    "data['Intervention_Ent']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 410,
   "id": "00b6f0b3",
   "metadata": {},
   "outputs": [],
   "source": [
    "data['Intervention'] = data['Intervention'].replace('', 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 411,
   "id": "d872297e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Intervention\n",
       "0                                                                                         952\n",
       "Drug: Letrozole ,                                                                          19\n",
       "Drug: Trastuzumab ,                                                                        17\n",
       "Drug: Capecitabine ,                                                                       17\n",
       "Drug: Fulvestrant ,                                                                        15\n",
       "                                                                                         ... \n",
       "Genetic: INGN 201 ,                                                                         1\n",
       "Behavioral: Telephone Genetic Counseling , Behavioral: Usual Care ,                         1\n",
       "Drug: Lapatinib (GW572016) oral tablets , Drug: Paclitaxel infusion , Drug: Placebo ,       1\n",
       "Drug: Lovastatin ,                                                                          1\n",
       "Drug: Camrelizumab Plus Chemotherapy , Drug: placebo+chemotherapy ,                         1\n",
       "Name: count, Length: 9570, dtype: int64"
      ]
     },
     "execution_count": 411,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data['Intervention'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 412,
   "id": "747e3d4b",
   "metadata": {},
   "outputs": [],
   "source": [
    "def clean_intervention(text:str):\n",
    "    drug = \"Drug: \"\n",
    "    intervention = []\n",
    "    if drug in text:    \n",
    "        text = text.rstrip(\" ,\")\n",
    "        list_text = text.split(' , ')\n",
    "        num_int = len(list_text)\n",
    "        for value in list_text:\n",
    "            if drug in value:\n",
    "                value = value.replace(drug, \"\")\n",
    "                intervention.append(value)\n",
    "                \n",
    "        \n",
    "    return intervention\n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 413,
   "id": "ad006b86",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Intervention\n",
       "0                                                                                         952\n",
       "Drug: Letrozole ,                                                                          19\n",
       "Drug: Trastuzumab ,                                                                        17\n",
       "Drug: Capecitabine ,                                                                       17\n",
       "Drug: Fulvestrant ,                                                                        15\n",
       "                                                                                         ... \n",
       "Genetic: INGN 201 ,                                                                         1\n",
       "Behavioral: Telephone Genetic Counseling , Behavioral: Usual Care ,                         1\n",
       "Drug: Lapatinib (GW572016) oral tablets , Drug: Paclitaxel infusion , Drug: Placebo ,       1\n",
       "Drug: Lovastatin ,                                                                          1\n",
       "Drug: Camrelizumab Plus Chemotherapy , Drug: placebo+chemotherapy ,                         1\n",
       "Name: count, Length: 9570, dtype: int64"
      ]
     },
     "execution_count": 413,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data['Intervention'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 414,
   "id": "3cde9917",
   "metadata": {},
   "outputs": [],
   "source": [
    "#First filter, we remove 952 trials with intervention 0 (without set intervention)\n",
    "data = data[data['Intervention'] != 0]\n",
    "data[\"Intervention\"] = data[\"Intervention\"].apply(clean_intervention)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 415,
   "id": "59c812e0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0                                                       []\n",
      "1                    [Paclitaxel, Bevacizumab, Exemestane]\n",
      "2        [BMK120, Capecitabine, BYL719, Trastuzumab, La...\n",
      "3                                                       []\n",
      "4                                              [Cipatinib]\n",
      "                               ...                        \n",
      "11388                                                   []\n",
      "11389                                                   []\n",
      "11390                                          [Poly ICLC]\n",
      "11391                                                   []\n",
      "11393    [Camrelizumab Plus Chemotherapy, placebo+chemo...\n",
      "Name: Intervention, Length: 10442, dtype: object\n",
      "10442\n"
     ]
    }
   ],
   "source": [
    "print(data[\"Intervention\"])\n",
    "print(data.shape[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 416,
   "id": "0f3db43d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTID</th>\n",
       "      <th>Phase</th>\n",
       "      <th>Status</th>\n",
       "      <th>Allocation</th>\n",
       "      <th>Intervention_Model</th>\n",
       "      <th>Intervention</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Criteria</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>ArmsNumber</th>\n",
       "      <th>...</th>\n",
       "      <th>Mesh_Term</th>\n",
       "      <th>Inclusion_Criteria</th>\n",
       "      <th>Exclusion_Criteria</th>\n",
       "      <th>Inclusion_Ent</th>\n",
       "      <th>Exclusion_Ent</th>\n",
       "      <th>Intervention_Ent</th>\n",
       "      <th>Conditions_Ent</th>\n",
       "      <th>Mesh_Term_Ent</th>\n",
       "      <th>Select Disease</th>\n",
       "      <th>Select Mesh</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01303679</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>[Paclitaxel, Bevacizumab, Exemestane]</td>\n",
       "      <td>First Line Metastatic Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>117</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>inclusion criteria . age 18 ans. . metastatic ...</td>\n",
       "      <td>. previous treatment by exemestane . . 1st lin...</td>\n",
       "      <td>{(breast cancer, DISEASE)}</td>\n",
       "      <td>{(coagulopathy, DISEASE), (thrombosis, DISEASE...</td>\n",
       "      <td>[Exemestane, Paclitaxel]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT01300962</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>[BMK120, Capecitabine, BYL719, Trastuzumab, La...</td>\n",
       "      <td>Metastatic Breast Cancer</td>\n",
       "      <td>\\n        PATIENT ELIGIBILITY Inclusion Criter...</td>\n",
       "      <td>47</td>\n",
       "      <td>4</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>patient eligibility inclusion criteria . age 1...</td>\n",
       "      <td>subjects meeting any of the exclusion criteria...</td>\n",
       "      <td>{(recist, DISEASE), (magnesium, CHEMICAL), (gl...</td>\n",
       "      <td>{(allergic reactions, DISEASE), (schizophrenia...</td>\n",
       "      <td>[Lapatinib, BYL719, Capecitabine]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT01301911</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>[Cipatinib]</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>26</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>inclusion criteria . aged 18 and 65 years. . e...</td>\n",
       "      <td>. subjects with third space fluid that can not...</td>\n",
       "      <td>{(creatinine, CHEMICAL), (breast cancer, DISEA...</td>\n",
       "      <td>{(arrhythmia, DISEASE), (epilepsy, DISEASE), (...</td>\n",
       "      <td>[]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01307891</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>[Abraxane alone, Abraxane + Tigatuzumab]</td>\n",
       "      <td>Breast Cancer , Triple Negative Breast Cancer ...</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>64</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>inclusion criteria . patients must have pathol...</td>\n",
       "      <td>. patients may not be receiving any other inve...</td>\n",
       "      <td>{(bisphosphonates, CHEMICAL), (progesterone, C...</td>\n",
       "      <td>{(psychiatric illness, DISEASE), (hiv or hepat...</td>\n",
       "      <td>[Abraxane]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01304797</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>[MM-302 Monotherapy, MM-302 in combination wit...</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>75</td>\n",
       "      <td>4</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>inclusion criteria . locally advanced unresect...</td>\n",
       "      <td>. patients for whom potentially curative antic...</td>\n",
       "      <td>{(breast cancer, DISEASE)}</td>\n",
       "      <td>{(fever, DISEASE), (hypersensitivity, DISEASE)...</td>\n",
       "      <td>[trastuzumab, cyclophosphamide]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5568</th>\n",
       "      <td>NCT04610528</td>\n",
       "      <td>Early Phase 1</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>[U3 1402, U3 1402]</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>80</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>inclusion criteria 1. written icf for all stud...</td>\n",
       "      <td>1. inoperable locally advanced or inflammatory...</td>\n",
       "      <td>{(progesterone, CHEMICAL), (alanine, CHEMICAL)...</td>\n",
       "      <td>{(infection, DISEASE), (cardiac arrhythmia, DI...</td>\n",
       "      <td>[]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5569</th>\n",
       "      <td>NCT04616729</td>\n",
       "      <td>Phase 1/Phase 2</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>[Triptorelin 3.75 MG Injection, Triptorelin In...</td>\n",
       "      <td>Breast Cancer Female</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>30</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>inclusion criteria . age 36y . bmi 18 and 35 k...</td>\n",
       "      <td>. contra.indications for controlled ovarian st...</td>\n",
       "      <td>{(breast cancer, DISEASE)}</td>\n",
       "      <td>{(ovarian, DISEASE)}</td>\n",
       "      <td>[Triptorelin]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5570</th>\n",
       "      <td>NCT04614194</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>[Letrozole, Abemaciclib]</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>\\n        INCLUSION CRITERIA:\\r\\n\\r\\n         ...</td>\n",
       "      <td>60</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>inclusion criteria . clinical stage operable s...</td>\n",
       "      <td>0</td>\n",
       "      <td>{(progesterone, CHEMICAL), (allergic reactions...</td>\n",
       "      <td>None</td>\n",
       "      <td>[Letrozole]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5571</th>\n",
       "      <td>NCT04616248</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Sequential Assignment</td>\n",
       "      <td>[Poly ICLC]</td>\n",
       "      <td>Anatomic Stage IV Breast Cancer AJCC v8 , Meta...</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>18</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>inclusion criteria . have clinically or pathol...</td>\n",
       "      <td>. patients currently treated with systemic imm...</td>\n",
       "      <td>{(alanine, CHEMICAL), (creatinine, CHEMICAL), ...</td>\n",
       "      <td>{(autoimmune disease, DISEASE), (cancer, DISEA...</td>\n",
       "      <td>[Poly ICLC]</td>\n",
       "      <td>{(Breast Cancer AJCC, DISEASE), (Breast Carcin...</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5572</th>\n",
       "      <td>NCT04613674</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>[Camrelizumab Plus Chemotherapy, placebo+chemo...</td>\n",
       "      <td>Triple Negative Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>581</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>inclusion criteria . ecog performance status o...</td>\n",
       "      <td>. has a history of breast cancer. . has a hist...</td>\n",
       "      <td>{(tumor, DISEASE)}</td>\n",
       "      <td>{(breast cancer, DISEASE), (anti.programmed, D...</td>\n",
       "      <td>[]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5573 rows × 28 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            NCTID            Phase          Status      Allocation   \n",
       "0     NCT01303679          Phase 3      Terminated      Randomized  \\\n",
       "1     NCT01300962          Phase 1       Completed  Non-Randomized   \n",
       "2     NCT01301911          Phase 1      Terminated             N/A   \n",
       "3     NCT01307891          Phase 2       Completed      Randomized   \n",
       "4     NCT01304797          Phase 1  Unknown status  Non-Randomized   \n",
       "...           ...              ...             ...             ...   \n",
       "5568  NCT04610528    Early Phase 1      Recruiting             N/A   \n",
       "5569  NCT04616729  Phase 1/Phase 2  Unknown status      Randomized   \n",
       "5570  NCT04614194          Phase 2      Recruiting      Randomized   \n",
       "5571  NCT04616248          Phase 1      Recruiting  Non-Randomized   \n",
       "5572  NCT04613674          Phase 3      Recruiting      Randomized   \n",
       "\n",
       "           Intervention_Model   \n",
       "0         Parallel Assignment  \\\n",
       "1     Single Group Assignment   \n",
       "2     Single Group Assignment   \n",
       "3         Parallel Assignment   \n",
       "4     Single Group Assignment   \n",
       "...                       ...   \n",
       "5568  Single Group Assignment   \n",
       "5569      Parallel Assignment   \n",
       "5570      Parallel Assignment   \n",
       "5571    Sequential Assignment   \n",
       "5572      Parallel Assignment   \n",
       "\n",
       "                                           Intervention   \n",
       "0                 [Paclitaxel, Bevacizumab, Exemestane]  \\\n",
       "1     [BMK120, Capecitabine, BYL719, Trastuzumab, La...   \n",
       "2                                           [Cipatinib]   \n",
       "3              [Abraxane alone, Abraxane + Tigatuzumab]   \n",
       "4     [MM-302 Monotherapy, MM-302 in combination wit...   \n",
       "...                                                 ...   \n",
       "5568                                 [U3 1402, U3 1402]   \n",
       "5569  [Triptorelin 3.75 MG Injection, Triptorelin In...   \n",
       "5570                           [Letrozole, Abemaciclib]   \n",
       "5571                                        [Poly ICLC]   \n",
       "5572  [Camrelizumab Plus Chemotherapy, placebo+chemo...   \n",
       "\n",
       "                                             Conditions   \n",
       "0                   First Line Metastatic Breast Cancer  \\\n",
       "1                              Metastatic Breast Cancer   \n",
       "2                                         Breast Cancer   \n",
       "3     Breast Cancer , Triple Negative Breast Cancer ...   \n",
       "4                                         Breast Cancer   \n",
       "...                                                 ...   \n",
       "5568                                      Breast Cancer   \n",
       "5569                               Breast Cancer Female   \n",
       "5570                                      Breast Cancer   \n",
       "5571  Anatomic Stage IV Breast Cancer AJCC v8 , Meta...   \n",
       "5572                      Triple Negative Breast Cancer   \n",
       "\n",
       "                                               Criteria Enrollment ArmsNumber   \n",
       "0     \\n        Inclusion Criteria:\\r\\n\\r\\n         ...        117          2  \\\n",
       "1     \\n        PATIENT ELIGIBILITY Inclusion Criter...         47          4   \n",
       "2     \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         26          1   \n",
       "3     \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         64          2   \n",
       "4     \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         75          4   \n",
       "...                                                 ...        ...        ...   \n",
       "5568  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         80          1   \n",
       "5569  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         30          2   \n",
       "5570  \\n        INCLUSION CRITERIA:\\r\\n\\r\\n         ...         60          2   \n",
       "5571  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         18          2   \n",
       "5572  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...        581          2   \n",
       "\n",
       "      ...         Mesh_Term   \n",
       "0     ...  Breast Neoplasms  \\\n",
       "1     ...  Breast Neoplasms   \n",
       "2     ...  Breast Neoplasms   \n",
       "3     ...  Breast Neoplasms   \n",
       "4     ...  Breast Neoplasms   \n",
       "...   ...               ...   \n",
       "5568  ...  Breast Neoplasms   \n",
       "5569  ...  Breast Neoplasms   \n",
       "5570  ...  Breast Neoplasms   \n",
       "5571  ...         Carcinoma   \n",
       "5572  ...  Breast Neoplasms   \n",
       "\n",
       "                                     Inclusion_Criteria   \n",
       "0     inclusion criteria . age 18 ans. . metastatic ...  \\\n",
       "1     patient eligibility inclusion criteria . age 1...   \n",
       "2     inclusion criteria . aged 18 and 65 years. . e...   \n",
       "3     inclusion criteria . patients must have pathol...   \n",
       "4     inclusion criteria . locally advanced unresect...   \n",
       "...                                                 ...   \n",
       "5568  inclusion criteria 1. written icf for all stud...   \n",
       "5569  inclusion criteria . age 36y . bmi 18 and 35 k...   \n",
       "5570  inclusion criteria . clinical stage operable s...   \n",
       "5571  inclusion criteria . have clinically or pathol...   \n",
       "5572  inclusion criteria . ecog performance status o...   \n",
       "\n",
       "                                     Exclusion_Criteria   \n",
       "0     . previous treatment by exemestane . . 1st lin...  \\\n",
       "1     subjects meeting any of the exclusion criteria...   \n",
       "2     . subjects with third space fluid that can not...   \n",
       "3     . patients may not be receiving any other inve...   \n",
       "4     . patients for whom potentially curative antic...   \n",
       "...                                                 ...   \n",
       "5568  1. inoperable locally advanced or inflammatory...   \n",
       "5569  . contra.indications for controlled ovarian st...   \n",
       "5570                                                  0   \n",
       "5571  . patients currently treated with systemic imm...   \n",
       "5572  . has a history of breast cancer. . has a hist...   \n",
       "\n",
       "                                          Inclusion_Ent   \n",
       "0                            {(breast cancer, DISEASE)}  \\\n",
       "1     {(recist, DISEASE), (magnesium, CHEMICAL), (gl...   \n",
       "2     {(creatinine, CHEMICAL), (breast cancer, DISEA...   \n",
       "3     {(bisphosphonates, CHEMICAL), (progesterone, C...   \n",
       "4                            {(breast cancer, DISEASE)}   \n",
       "...                                                 ...   \n",
       "5568  {(progesterone, CHEMICAL), (alanine, CHEMICAL)...   \n",
       "5569                         {(breast cancer, DISEASE)}   \n",
       "5570  {(progesterone, CHEMICAL), (allergic reactions...   \n",
       "5571  {(alanine, CHEMICAL), (creatinine, CHEMICAL), ...   \n",
       "5572                                 {(tumor, DISEASE)}   \n",
       "\n",
       "                                          Exclusion_Ent   \n",
       "0     {(coagulopathy, DISEASE), (thrombosis, DISEASE...  \\\n",
       "1     {(allergic reactions, DISEASE), (schizophrenia...   \n",
       "2     {(arrhythmia, DISEASE), (epilepsy, DISEASE), (...   \n",
       "3     {(psychiatric illness, DISEASE), (hiv or hepat...   \n",
       "4     {(fever, DISEASE), (hypersensitivity, DISEASE)...   \n",
       "...                                                 ...   \n",
       "5568  {(infection, DISEASE), (cardiac arrhythmia, DI...   \n",
       "5569                               {(ovarian, DISEASE)}   \n",
       "5570                                               None   \n",
       "5571  {(autoimmune disease, DISEASE), (cancer, DISEA...   \n",
       "5572  {(breast cancer, DISEASE), (anti.programmed, D...   \n",
       "\n",
       "                       Intervention_Ent   \n",
       "0              [Exemestane, Paclitaxel]  \\\n",
       "1     [Lapatinib, BYL719, Capecitabine]   \n",
       "2                                    []   \n",
       "3                            [Abraxane]   \n",
       "4       [trastuzumab, cyclophosphamide]   \n",
       "...                                 ...   \n",
       "5568                                 []   \n",
       "5569                      [Triptorelin]   \n",
       "5570                        [Letrozole]   \n",
       "5571                        [Poly ICLC]   \n",
       "5572                                 []   \n",
       "\n",
       "                                         Conditions_Ent Mesh_Term_Ent   \n",
       "0                            {(Breast Cancer, DISEASE)}            {}  \\\n",
       "1                            {(Breast Cancer, DISEASE)}            {}   \n",
       "2                            {(Breast Cancer, DISEASE)}            {}   \n",
       "3                            {(Breast Cancer, DISEASE)}            {}   \n",
       "4                            {(Breast Cancer, DISEASE)}            {}   \n",
       "...                                                 ...           ...   \n",
       "5568                         {(Breast Cancer, DISEASE)}            {}   \n",
       "5569                         {(Breast Cancer, DISEASE)}            {}   \n",
       "5570                         {(Breast Cancer, DISEASE)}            {}   \n",
       "5571  {(Breast Cancer AJCC, DISEASE), (Breast Carcin...            {}   \n",
       "5572                         {(Breast Cancer, DISEASE)}            {}   \n",
       "\n",
       "     Select Disease Select Mesh  \n",
       "0              True        True  \n",
       "1              True        True  \n",
       "2              True        True  \n",
       "3              True        True  \n",
       "4              True        True  \n",
       "...             ...         ...  \n",
       "5568           True        True  \n",
       "5569           True        True  \n",
       "5570           True        True  \n",
       "5571           True       False  \n",
       "5572           True        True  \n",
       "\n",
       "[5573 rows x 28 columns]"
      ]
     },
     "execution_count": 416,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Second filter, we remove trials that their intervention is not drug type\n",
    "data = data[data['Intervention'].apply(lambda x: isinstance(x,list) and len(x) > 0)].reset_index()\n",
    "data = data.drop('index', axis=1)\n",
    "data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 417,
   "id": "c23f4755",
   "metadata": {},
   "outputs": [],
   "source": [
    "# replacing the drug name in the Intervention column with the drug name entity from the \n",
    "# Interventuon_Ent column\n",
    "for index, row in data.iterrows():\n",
    "    intervention = row[\"Intervention\"]\n",
    "    new_list = intervention\n",
    "    \n",
    "    for i in new_list:\n",
    "        if i.lower() == \"placebo\":\n",
    "            new_list.remove(i)\n",
    "        \n",
    "    interven_ent = row[\"Intervention_Ent\"]\n",
    "    for ent in interven_ent:\n",
    "        indices = [i for i, string in enumerate(intervention) if ent in string]\n",
    "        for i in indices:\n",
    "            new_list[i] = str(ent)\n",
    "    row[\"Intervention\"] = new_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 418,
   "id": "5e0c069c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Aromasin']"
      ]
     },
     "execution_count": 418,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data['Intervention_Ent'][10]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "937951ca",
   "metadata": {},
   "source": [
    "# Cleaning Phase"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 419,
   "id": "42cadb17",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Phase\n",
       "Phase 2            2368\n",
       "Phase 1             885\n",
       "Phase 3             877\n",
       "Phase 1/Phase 2     519\n",
       "0                   272\n",
       "N/A                 257\n",
       "Phase 4             191\n",
       "Early Phase 1       117\n",
       "Phase 2/Phase 3      87\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 419,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data['Phase'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 420,
   "id": "687bd211",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Series([], Name: NCTID, dtype: object)"
      ]
     },
     "execution_count": 420,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data[data['Phase'] == 5][\"NCTID\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 421,
   "id": "7eb471f6",
   "metadata": {},
   "outputs": [],
   "source": [
    "data['Phase'] = data['Phase'].replace('N/A',5)\n",
    "data['Phase'] = data['Phase'].replace('Phase 1', 1)\n",
    "data['Phase'] = data['Phase'].replace('Early Phase 1', 1)\n",
    "data['Phase'] = data['Phase'].replace('Phase 1/Phase 2', 2)\n",
    "data['Phase'] = data['Phase'].replace('Phase 2/Phase 3', 3)\n",
    "data['Phase'] = data['Phase'].replace('Phase 2', 2)\n",
    "data['Phase'] = data['Phase'].replace('Phase 3', 3)\n",
    "data['Phase'] = data['Phase'].replace('Phase 4', 4)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 422,
   "id": "0bc293b3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Phase\n",
       "2    2887\n",
       "1    1002\n",
       "3     964\n",
       "0     272\n",
       "5     257\n",
       "4     191\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 422,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data['Phase'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 423,
   "id": "2653fa35",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Status\n",
       "Completed                  2487\n",
       "Recruiting                  877\n",
       "Terminated                  629\n",
       "Active, not recruiting      551\n",
       "Unknown status              541\n",
       "Not yet recruiting          230\n",
       "Withdrawn                   205\n",
       "Suspended                    17\n",
       "Enrolling by invitation      13\n",
       "No longer available          11\n",
       "Available                     6\n",
       "Approved for marketing        6\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 423,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data['Status'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 441,
   "id": "9339d600",
   "metadata": {},
   "outputs": [],
   "source": [
    "import itertools\n",
    "\n",
    "drug_lst_phase_1 = list(itertools.chain.from_iterable(list(data[data['Phase'] == 1]['Intervention'])))\n",
    "drug_lst_phase_2 = list(itertools.chain.from_iterable(list(data[data['Phase'] == 2]['Intervention'])))\n",
    "drug_lst_phase_3 = list(itertools.chain.from_iterable(list(data[data['Phase'] == 3]['Intervention'])))\n",
    "drug_lst_phase_4 = list(itertools.chain.from_iterable(list(data[data['Phase'] == 4]['Intervention'])))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 443,
   "id": "4388e6c4",
   "metadata": {},
   "outputs": [],
   "source": [
    "data['Label'] = True\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 444,
   "id": "06512539",
   "metadata": {},
   "outputs": [],
   "source": [
    "def switch_case_label(phase, drug):\n",
    "    res = False\n",
    "#     print(phase, drug)\n",
    "    if phase == 1:\n",
    "        res = ((drug in drug_lst_phase_2) or\n",
    "               (drug in drug_lst_phase_3 ) or\n",
    "               (drug in drug_lst_phase_4))\n",
    "        return res\n",
    "    elif phase == 2:\n",
    "        res = ((drug in drug_lst_phase_3 ) or\n",
    "           (drug in drug_lst_phase_4))\n",
    "        return res\n",
    "    \n",
    "    elif phase == 3:\n",
    "        res = ((drug in drug_lst_phase_4))\n",
    "        return res\n",
    "    else:\n",
    "        return False"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 445,
   "id": "2a0036a9",
   "metadata": {},
   "outputs": [],
   "source": [
    "failed_label=['Terminated', 'Withdrawn', 'Suspended']\n",
    "\n",
    "for index, row in data.iterrows():\n",
    "    drugs = row['Intervention']\n",
    "    status = row['Status']\n",
    "    phase = int(row['Phase'])\n",
    "    result = []\n",
    "    if status == \"Completed\":\n",
    "        result = [switch_case_label(phase, drug) for drug in drugs]\n",
    "        label = any(result)\n",
    "        data.loc[index, 'Label'] = label\n",
    "#         print(label)\n",
    "#         print(\"********\")\n",
    "    \n",
    "    \n",
    "    \n",
    "    if status in failed_label:\n",
    "        data.loc[index, 'Label'] = False"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 446,
   "id": "f56d4484",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Label\n",
       "True     3793\n",
       "False    1780\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 446,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data['Label'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 447,
   "id": "c5340890",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTID</th>\n",
       "      <th>Phase</th>\n",
       "      <th>Status</th>\n",
       "      <th>Allocation</th>\n",
       "      <th>Intervention_Model</th>\n",
       "      <th>Intervention</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Criteria</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>ArmsNumber</th>\n",
       "      <th>...</th>\n",
       "      <th>Inclusion_Criteria</th>\n",
       "      <th>Exclusion_Criteria</th>\n",
       "      <th>Inclusion_Ent</th>\n",
       "      <th>Exclusion_Ent</th>\n",
       "      <th>Intervention_Ent</th>\n",
       "      <th>Conditions_Ent</th>\n",
       "      <th>Mesh_Term_Ent</th>\n",
       "      <th>Select Disease</th>\n",
       "      <th>Select Mesh</th>\n",
       "      <th>Label</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01303679</td>\n",
       "      <td>3</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>[Paclitaxel, Bevacizumab, Exemestane]</td>\n",
       "      <td>First Line Metastatic Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>117</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>inclusion criteria . age 18 ans. . metastatic ...</td>\n",
       "      <td>. previous treatment by exemestane . . 1st lin...</td>\n",
       "      <td>{(breast cancer, DISEASE)}</td>\n",
       "      <td>{(coagulopathy, DISEASE), (thrombosis, DISEASE...</td>\n",
       "      <td>[Exemestane, Paclitaxel]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT01300962</td>\n",
       "      <td>1</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>[BMK120, Capecitabine, BYL719, Trastuzumab, La...</td>\n",
       "      <td>Metastatic Breast Cancer</td>\n",
       "      <td>\\n        PATIENT ELIGIBILITY Inclusion Criter...</td>\n",
       "      <td>47</td>\n",
       "      <td>4</td>\n",
       "      <td>...</td>\n",
       "      <td>patient eligibility inclusion criteria . age 1...</td>\n",
       "      <td>subjects meeting any of the exclusion criteria...</td>\n",
       "      <td>{(recist, DISEASE), (magnesium, CHEMICAL), (gl...</td>\n",
       "      <td>{(allergic reactions, DISEASE), (schizophrenia...</td>\n",
       "      <td>[Lapatinib, BYL719, Capecitabine]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT01301911</td>\n",
       "      <td>1</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>[Cipatinib]</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>26</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>inclusion criteria . aged 18 and 65 years. . e...</td>\n",
       "      <td>. subjects with third space fluid that can not...</td>\n",
       "      <td>{(creatinine, CHEMICAL), (breast cancer, DISEA...</td>\n",
       "      <td>{(arrhythmia, DISEASE), (epilepsy, DISEASE), (...</td>\n",
       "      <td>[]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01307891</td>\n",
       "      <td>2</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>[Abraxane, Abraxane]</td>\n",
       "      <td>Breast Cancer , Triple Negative Breast Cancer ...</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>64</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>inclusion criteria . patients must have pathol...</td>\n",
       "      <td>. patients may not be receiving any other inve...</td>\n",
       "      <td>{(bisphosphonates, CHEMICAL), (progesterone, C...</td>\n",
       "      <td>{(psychiatric illness, DISEASE), (hiv or hepat...</td>\n",
       "      <td>[Abraxane]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01304797</td>\n",
       "      <td>1</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>[MM-302 Monotherapy, trastuzumab, trastuzumab,...</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>75</td>\n",
       "      <td>4</td>\n",
       "      <td>...</td>\n",
       "      <td>inclusion criteria . locally advanced unresect...</td>\n",
       "      <td>. patients for whom potentially curative antic...</td>\n",
       "      <td>{(breast cancer, DISEASE)}</td>\n",
       "      <td>{(fever, DISEASE), (hypersensitivity, DISEASE)...</td>\n",
       "      <td>[trastuzumab, cyclophosphamide]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 29 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         NCTID  Phase          Status      Allocation   \n",
       "0  NCT01303679      3      Terminated      Randomized  \\\n",
       "1  NCT01300962      1       Completed  Non-Randomized   \n",
       "2  NCT01301911      1      Terminated             N/A   \n",
       "3  NCT01307891      2       Completed      Randomized   \n",
       "4  NCT01304797      1  Unknown status  Non-Randomized   \n",
       "\n",
       "        Intervention_Model                                       Intervention   \n",
       "0      Parallel Assignment              [Paclitaxel, Bevacizumab, Exemestane]  \\\n",
       "1  Single Group Assignment  [BMK120, Capecitabine, BYL719, Trastuzumab, La...   \n",
       "2  Single Group Assignment                                        [Cipatinib]   \n",
       "3      Parallel Assignment                               [Abraxane, Abraxane]   \n",
       "4  Single Group Assignment  [MM-302 Monotherapy, trastuzumab, trastuzumab,...   \n",
       "\n",
       "                                          Conditions   \n",
       "0                First Line Metastatic Breast Cancer  \\\n",
       "1                           Metastatic Breast Cancer   \n",
       "2                                      Breast Cancer   \n",
       "3  Breast Cancer , Triple Negative Breast Cancer ...   \n",
       "4                                      Breast Cancer   \n",
       "\n",
       "                                            Criteria Enrollment ArmsNumber   \n",
       "0  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...        117          2  \\\n",
       "1  \\n        PATIENT ELIGIBILITY Inclusion Criter...         47          4   \n",
       "2  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         26          1   \n",
       "3  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         64          2   \n",
       "4  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         75          4   \n",
       "\n",
       "   ...                                 Inclusion_Criteria   \n",
       "0  ...  inclusion criteria . age 18 ans. . metastatic ...  \\\n",
       "1  ...  patient eligibility inclusion criteria . age 1...   \n",
       "2  ...  inclusion criteria . aged 18 and 65 years. . e...   \n",
       "3  ...  inclusion criteria . patients must have pathol...   \n",
       "4  ...  inclusion criteria . locally advanced unresect...   \n",
       "\n",
       "                                  Exclusion_Criteria   \n",
       "0  . previous treatment by exemestane . . 1st lin...  \\\n",
       "1  subjects meeting any of the exclusion criteria...   \n",
       "2  . subjects with third space fluid that can not...   \n",
       "3  . patients may not be receiving any other inve...   \n",
       "4  . patients for whom potentially curative antic...   \n",
       "\n",
       "                                       Inclusion_Ent   \n",
       "0                         {(breast cancer, DISEASE)}  \\\n",
       "1  {(recist, DISEASE), (magnesium, CHEMICAL), (gl...   \n",
       "2  {(creatinine, CHEMICAL), (breast cancer, DISEA...   \n",
       "3  {(bisphosphonates, CHEMICAL), (progesterone, C...   \n",
       "4                         {(breast cancer, DISEASE)}   \n",
       "\n",
       "                                       Exclusion_Ent   \n",
       "0  {(coagulopathy, DISEASE), (thrombosis, DISEASE...  \\\n",
       "1  {(allergic reactions, DISEASE), (schizophrenia...   \n",
       "2  {(arrhythmia, DISEASE), (epilepsy, DISEASE), (...   \n",
       "3  {(psychiatric illness, DISEASE), (hiv or hepat...   \n",
       "4  {(fever, DISEASE), (hypersensitivity, DISEASE)...   \n",
       "\n",
       "                    Intervention_Ent              Conditions_Ent   \n",
       "0           [Exemestane, Paclitaxel]  {(Breast Cancer, DISEASE)}  \\\n",
       "1  [Lapatinib, BYL719, Capecitabine]  {(Breast Cancer, DISEASE)}   \n",
       "2                                 []  {(Breast Cancer, DISEASE)}   \n",
       "3                         [Abraxane]  {(Breast Cancer, DISEASE)}   \n",
       "4    [trastuzumab, cyclophosphamide]  {(Breast Cancer, DISEASE)}   \n",
       "\n",
       "  Mesh_Term_Ent Select Disease Select Mesh  Label  \n",
       "0            {}           True        True  False  \n",
       "1            {}           True        True   True  \n",
       "2            {}           True        True  False  \n",
       "3            {}           True        True   True  \n",
       "4            {}           True        True   True  \n",
       "\n",
       "[5 rows x 29 columns]"
      ]
     },
     "execution_count": 447,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 455,
   "id": "1f07207e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['NCTID', 'Phase', 'Status', 'Allocation', 'Intervention_Model',\n",
       "       'Intervention', 'Conditions', 'Criteria', 'Enrollment', 'ArmsNumber',\n",
       "       'has_dmc', 'is_fda_regulated_drug', 'is_fda_regulated_device',\n",
       "       'Sponsors', 'Age_Min', 'Age_Max', 'Gender', 'Countries', 'Mesh_Term',\n",
       "       'Inclusion_Criteria', 'Exclusion_Criteria', 'Inclusion_Ent',\n",
       "       'Exclusion_Ent', 'Intervention_Ent', 'Conditions_Ent', 'Mesh_Term_Ent',\n",
       "       'Select Disease', 'Select Mesh', 'Label'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 455,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 448,
   "id": "9370313b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Label\n",
       "False    1780\n",
       "True     1564\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 448,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "accepted_label = ['Terminated', 'Withdrawn', 'Suspended', 'Completed', 'Approved for marketing' ]\n",
    "data_filterd = data[data[\"Status\"].isin(accepted_label)]\n",
    "data_filterd['Label'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 463,
   "id": "2d9ff88a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Intervention_Ent\n",
       "[]                                       584\n",
       "[Letrozole]                               49\n",
       "[Paclitaxel]                              46\n",
       "[Fulvestrant]                             33\n",
       "[Capecitabine]                            32\n",
       "                                        ... \n",
       "[Eplerenone]                               1\n",
       "[GRN163L]                                  1\n",
       "[SCH 727965, Capecitabine, Erlotinib]      1\n",
       "[Tarceva]                                  1\n",
       "[LDE225]                                   1\n",
       "Name: count, Length: 1818, dtype: int64"
      ]
     },
     "execution_count": 463,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_filterd['Intervention_Ent'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 449,
   "id": "f37a10af",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCTID</th>\n",
       "      <th>Phase</th>\n",
       "      <th>Status</th>\n",
       "      <th>Allocation</th>\n",
       "      <th>Intervention_Model</th>\n",
       "      <th>Intervention</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Criteria</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>ArmsNumber</th>\n",
       "      <th>...</th>\n",
       "      <th>Inclusion_Criteria</th>\n",
       "      <th>Exclusion_Criteria</th>\n",
       "      <th>Inclusion_Ent</th>\n",
       "      <th>Exclusion_Ent</th>\n",
       "      <th>Intervention_Ent</th>\n",
       "      <th>Conditions_Ent</th>\n",
       "      <th>Mesh_Term_Ent</th>\n",
       "      <th>Select Disease</th>\n",
       "      <th>Select Mesh</th>\n",
       "      <th>Label</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01303679</td>\n",
       "      <td>3</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>[Paclitaxel, Bevacizumab, Exemestane]</td>\n",
       "      <td>First Line Metastatic Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>117</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>inclusion criteria . age 18 ans. . metastatic ...</td>\n",
       "      <td>. previous treatment by exemestane . . 1st lin...</td>\n",
       "      <td>{(breast cancer, DISEASE)}</td>\n",
       "      <td>{(coagulopathy, DISEASE), (thrombosis, DISEASE...</td>\n",
       "      <td>[Exemestane, Paclitaxel]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT01300962</td>\n",
       "      <td>1</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>[BMK120, Capecitabine, BYL719, Trastuzumab, La...</td>\n",
       "      <td>Metastatic Breast Cancer</td>\n",
       "      <td>\\n        PATIENT ELIGIBILITY Inclusion Criter...</td>\n",
       "      <td>47</td>\n",
       "      <td>4</td>\n",
       "      <td>...</td>\n",
       "      <td>patient eligibility inclusion criteria . age 1...</td>\n",
       "      <td>subjects meeting any of the exclusion criteria...</td>\n",
       "      <td>{(recist, DISEASE), (magnesium, CHEMICAL), (gl...</td>\n",
       "      <td>{(allergic reactions, DISEASE), (schizophrenia...</td>\n",
       "      <td>[Lapatinib, BYL719, Capecitabine]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT01301911</td>\n",
       "      <td>1</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>[Cipatinib]</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>26</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>inclusion criteria . aged 18 and 65 years. . e...</td>\n",
       "      <td>. subjects with third space fluid that can not...</td>\n",
       "      <td>{(creatinine, CHEMICAL), (breast cancer, DISEA...</td>\n",
       "      <td>{(arrhythmia, DISEASE), (epilepsy, DISEASE), (...</td>\n",
       "      <td>[]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01307891</td>\n",
       "      <td>2</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>[Abraxane, Abraxane]</td>\n",
       "      <td>Breast Cancer , Triple Negative Breast Cancer ...</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>64</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>inclusion criteria . patients must have pathol...</td>\n",
       "      <td>. patients may not be receiving any other inve...</td>\n",
       "      <td>{(bisphosphonates, CHEMICAL), (progesterone, C...</td>\n",
       "      <td>{(psychiatric illness, DISEASE), (hiv or hepat...</td>\n",
       "      <td>[Abraxane]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT01301040</td>\n",
       "      <td>2</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>[epirubicin]</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>\\n        1. Patient selection criteria\\r\\n\\r\\...</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>1. patient selection criteria . female aged eq...</td>\n",
       "      <td>0</td>\n",
       "      <td>{(luminal, CHEMICAL), (pulmonary conditions il...</td>\n",
       "      <td>None</td>\n",
       "      <td>[epirubicin, cyclophosphamide, docetaxel]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5562</th>\n",
       "      <td>NCT01575522</td>\n",
       "      <td>2</td>\n",
       "      <td>Completed</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>[Tivantinib]</td>\n",
       "      <td>Estrogen Receptor Negative , HER2/Neu Negative...</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>22</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>inclusion criteria . participants must have hi...</td>\n",
       "      <td>. participants who have received chemotherapy ...</td>\n",
       "      <td>{(bisphosphonates, CHEMICAL), (alanine, CHEMIC...</td>\n",
       "      <td>{(psychiatric illness, DISEASE), (allergic rea...</td>\n",
       "      <td>[Tivantinib]</td>\n",
       "      <td>{(Breast Cancer, DISEASE), (Progesterone, CHEM...</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5563</th>\n",
       "      <td>NCT01573442</td>\n",
       "      <td>3</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>[testosterone]</td>\n",
       "      <td>Arthralgia , Breast Cancer , Hot Flashes , Mus...</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>227</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>inclusion criteria 1. age 18 years 2. receivin...</td>\n",
       "      <td>1. presence of residual or recurrent cancer 2....</td>\n",
       "      <td>{(arthralgia, DISEASE), (letrozole, CHEMICAL),...</td>\n",
       "      <td>{(thromboembolism, DISEASE), (venous thrombosi...</td>\n",
       "      <td>[testosterone]</td>\n",
       "      <td>{(Breast Cancer, DISEASE), (Arthralgia, DISEAS...</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5564</th>\n",
       "      <td>NCT01570036</td>\n",
       "      <td>2</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>[Herceptin, NeuVax vaccine, GM-CSF]</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>\\n        Patients will be included in the stu...</td>\n",
       "      <td>275</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>patients will be included in the study based o...</td>\n",
       "      <td>0</td>\n",
       "      <td>{(pulmonary disease, DISEASE), (dual.ish, CHEM...</td>\n",
       "      <td>None</td>\n",
       "      <td>[]</td>\n",
       "      <td>{(Breast Cancer, DISEASE)}</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5566</th>\n",
       "      <td>NCT01576666</td>\n",
       "      <td>1</td>\n",
       "      <td>Completed</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>[LDE225, BKM120]</td>\n",
       "      <td>Dose Escalation , Safety , Preliminary Efficac...</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>120</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>inclusion criteria 1. male or female adult pat...</td>\n",
       "      <td>1.use of other investigational drugs within 30...</td>\n",
       "      <td>{(recist, DISEASE), (tumor, DISEASE), (breast ...</td>\n",
       "      <td>{(schizophrenia, DISEASE), (anxiety, DISEASE),...</td>\n",
       "      <td>[LDE225]</td>\n",
       "      <td>{(Breast Cancer, DISEASE), (Gastric Cancer, DI...</td>\n",
       "      <td>{}</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5567</th>\n",
       "      <td>NCT01572038</td>\n",
       "      <td>3</td>\n",
       "      <td>Completed</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>[Docetaxel, Nab-paclitaxel, Paclitaxel, Pertuz...</td>\n",
       "      <td>Breast Neoplasms</td>\n",
       "      <td>\\n        Inclusion Criteria:\\r\\n\\r\\n         ...</td>\n",
       "      <td>1436</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>inclusion criteria . histologically or cytolog...</td>\n",
       "      <td>. previous systemic non.hormonal anti.cancer t...</td>\n",
       "      <td>{(adenocarcinoma of the breast, DISEASE), (bre...</td>\n",
       "      <td>{(basal cell carcinoma, DISEASE), (trastuzumab...</td>\n",
       "      <td>[Nab-paclitaxel, Docetaxel, Paclitaxel]</td>\n",
       "      <td>{}</td>\n",
       "      <td>{}</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3344 rows × 29 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            NCTID  Phase      Status      Allocation       Intervention_Model   \n",
       "0     NCT01303679      3  Terminated      Randomized      Parallel Assignment  \\\n",
       "1     NCT01300962      1   Completed  Non-Randomized  Single Group Assignment   \n",
       "2     NCT01301911      1  Terminated             N/A  Single Group Assignment   \n",
       "3     NCT01307891      2   Completed      Randomized      Parallel Assignment   \n",
       "5     NCT01301040      2  Terminated      Randomized      Parallel Assignment   \n",
       "...           ...    ...         ...             ...                      ...   \n",
       "5562  NCT01575522      2   Completed             N/A  Single Group Assignment   \n",
       "5563  NCT01573442      3   Completed      Randomized      Parallel Assignment   \n",
       "5564  NCT01570036      2   Completed      Randomized      Parallel Assignment   \n",
       "5566  NCT01576666      1   Completed             N/A  Single Group Assignment   \n",
       "5567  NCT01572038      3   Completed             N/A  Single Group Assignment   \n",
       "\n",
       "                                           Intervention   \n",
       "0                 [Paclitaxel, Bevacizumab, Exemestane]  \\\n",
       "1     [BMK120, Capecitabine, BYL719, Trastuzumab, La...   \n",
       "2                                           [Cipatinib]   \n",
       "3                                  [Abraxane, Abraxane]   \n",
       "5                                          [epirubicin]   \n",
       "...                                                 ...   \n",
       "5562                                       [Tivantinib]   \n",
       "5563                                     [testosterone]   \n",
       "5564                [Herceptin, NeuVax vaccine, GM-CSF]   \n",
       "5566                                   [LDE225, BKM120]   \n",
       "5567  [Docetaxel, Nab-paclitaxel, Paclitaxel, Pertuz...   \n",
       "\n",
       "                                             Conditions   \n",
       "0                   First Line Metastatic Breast Cancer  \\\n",
       "1                              Metastatic Breast Cancer   \n",
       "2                                         Breast Cancer   \n",
       "3     Breast Cancer , Triple Negative Breast Cancer ...   \n",
       "5                                         Breast Cancer   \n",
       "...                                                 ...   \n",
       "5562  Estrogen Receptor Negative , HER2/Neu Negative...   \n",
       "5563  Arthralgia , Breast Cancer , Hot Flashes , Mus...   \n",
       "5564                                      Breast Cancer   \n",
       "5566  Dose Escalation , Safety , Preliminary Efficac...   \n",
       "5567                                   Breast Neoplasms   \n",
       "\n",
       "                                               Criteria Enrollment ArmsNumber   \n",
       "0     \\n        Inclusion Criteria:\\r\\n\\r\\n         ...        117          2  \\\n",
       "1     \\n        PATIENT ELIGIBILITY Inclusion Criter...         47          4   \n",
       "2     \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         26          1   \n",
       "3     \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         64          2   \n",
       "5     \\n        1. Patient selection criteria\\r\\n\\r\\...          2          2   \n",
       "...                                                 ...        ...        ...   \n",
       "5562  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...         22          1   \n",
       "5563  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...        227          2   \n",
       "5564  \\n        Patients will be included in the stu...        275          2   \n",
       "5566  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...        120          1   \n",
       "5567  \\n        Inclusion Criteria:\\r\\n\\r\\n         ...       1436          1   \n",
       "\n",
       "      ...                                 Inclusion_Criteria   \n",
       "0     ...  inclusion criteria . age 18 ans. . metastatic ...  \\\n",
       "1     ...  patient eligibility inclusion criteria . age 1...   \n",
       "2     ...  inclusion criteria . aged 18 and 65 years. . e...   \n",
       "3     ...  inclusion criteria . patients must have pathol...   \n",
       "5     ...  1. patient selection criteria . female aged eq...   \n",
       "...   ...                                                ...   \n",
       "5562  ...  inclusion criteria . participants must have hi...   \n",
       "5563  ...  inclusion criteria 1. age 18 years 2. receivin...   \n",
       "5564  ...  patients will be included in the study based o...   \n",
       "5566  ...  inclusion criteria 1. male or female adult pat...   \n",
       "5567  ...  inclusion criteria . histologically or cytolog...   \n",
       "\n",
       "                                     Exclusion_Criteria   \n",
       "0     . previous treatment by exemestane . . 1st lin...  \\\n",
       "1     subjects meeting any of the exclusion criteria...   \n",
       "2     . subjects with third space fluid that can not...   \n",
       "3     . patients may not be receiving any other inve...   \n",
       "5                                                     0   \n",
       "...                                                 ...   \n",
       "5562  . participants who have received chemotherapy ...   \n",
       "5563  1. presence of residual or recurrent cancer 2....   \n",
       "5564                                                  0   \n",
       "5566  1.use of other investigational drugs within 30...   \n",
       "5567  . previous systemic non.hormonal anti.cancer t...   \n",
       "\n",
       "                                          Inclusion_Ent   \n",
       "0                            {(breast cancer, DISEASE)}  \\\n",
       "1     {(recist, DISEASE), (magnesium, CHEMICAL), (gl...   \n",
       "2     {(creatinine, CHEMICAL), (breast cancer, DISEA...   \n",
       "3     {(bisphosphonates, CHEMICAL), (progesterone, C...   \n",
       "5     {(luminal, CHEMICAL), (pulmonary conditions il...   \n",
       "...                                                 ...   \n",
       "5562  {(bisphosphonates, CHEMICAL), (alanine, CHEMIC...   \n",
       "5563  {(arthralgia, DISEASE), (letrozole, CHEMICAL),...   \n",
       "5564  {(pulmonary disease, DISEASE), (dual.ish, CHEM...   \n",
       "5566  {(recist, DISEASE), (tumor, DISEASE), (breast ...   \n",
       "5567  {(adenocarcinoma of the breast, DISEASE), (bre...   \n",
       "\n",
       "                                          Exclusion_Ent   \n",
       "0     {(coagulopathy, DISEASE), (thrombosis, DISEASE...  \\\n",
       "1     {(allergic reactions, DISEASE), (schizophrenia...   \n",
       "2     {(arrhythmia, DISEASE), (epilepsy, DISEASE), (...   \n",
       "3     {(psychiatric illness, DISEASE), (hiv or hepat...   \n",
       "5                                                  None   \n",
       "...                                                 ...   \n",
       "5562  {(psychiatric illness, DISEASE), (allergic rea...   \n",
       "5563  {(thromboembolism, DISEASE), (venous thrombosi...   \n",
       "5564                                               None   \n",
       "5566  {(schizophrenia, DISEASE), (anxiety, DISEASE),...   \n",
       "5567  {(basal cell carcinoma, DISEASE), (trastuzumab...   \n",
       "\n",
       "                               Intervention_Ent   \n",
       "0                      [Exemestane, Paclitaxel]  \\\n",
       "1             [Lapatinib, BYL719, Capecitabine]   \n",
       "2                                            []   \n",
       "3                                    [Abraxane]   \n",
       "5     [epirubicin, cyclophosphamide, docetaxel]   \n",
       "...                                         ...   \n",
       "5562                               [Tivantinib]   \n",
       "5563                             [testosterone]   \n",
       "5564                                         []   \n",
       "5566                                   [LDE225]   \n",
       "5567    [Nab-paclitaxel, Docetaxel, Paclitaxel]   \n",
       "\n",
       "                                         Conditions_Ent Mesh_Term_Ent   \n",
       "0                            {(Breast Cancer, DISEASE)}            {}  \\\n",
       "1                            {(Breast Cancer, DISEASE)}            {}   \n",
       "2                            {(Breast Cancer, DISEASE)}            {}   \n",
       "3                            {(Breast Cancer, DISEASE)}            {}   \n",
       "5                            {(Breast Cancer, DISEASE)}            {}   \n",
       "...                                                 ...           ...   \n",
       "5562  {(Breast Cancer, DISEASE), (Progesterone, CHEM...            {}   \n",
       "5563  {(Breast Cancer, DISEASE), (Arthralgia, DISEAS...            {}   \n",
       "5564                         {(Breast Cancer, DISEASE)}            {}   \n",
       "5566  {(Breast Cancer, DISEASE), (Gastric Cancer, DI...            {}   \n",
       "5567                                                 {}            {}   \n",
       "\n",
       "     Select Disease Select Mesh  Label  \n",
       "0              True        True  False  \n",
       "1              True        True   True  \n",
       "2              True        True  False  \n",
       "3              True        True   True  \n",
       "5              True        True  False  \n",
       "...             ...         ...    ...  \n",
       "5562           True       False  False  \n",
       "5563           True        True  False  \n",
       "5564           True        True   True  \n",
       "5566           True        True   True  \n",
       "5567          False        True   True  \n",
       "\n",
       "[3344 rows x 29 columns]"
      ]
     },
     "execution_count": 449,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_filtered"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "66a6e66a",
   "metadata": {},
   "source": [
    "# UMLS"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 429,
   "id": "6b1a5ade",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'pageSize': 25, 'pageNumber': 1, 'result': {'classType': 'searchResults', 'results': [], 'recCount': 0}, 'partialSearch': 'https://uts-ws.nlm.nih.gov/rest/search/current?string=MM-302%20in%20combination%20with%20trastuzumab&partialSearch=true'}\n",
      "******\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "\n",
    "# # UMLS API endpoint\n",
    "API_URL = \"https://uts-ws.nlm.nih.gov/rest\"\n",
    "\n",
    "# UMLS API Key\n",
    "API_KEY = \"7db48636-e10b-4063-a1af-fead3b2122a8\"\n",
    "\n",
    "# Search for a term in UMLS\n",
    "def search_term(term):\n",
    "    # Construct the URL\n",
    " \n",
    "#     url = f\"https://uts-ws.nlm.nih.gov/rest/content/current/CUI/C0024121?apiKey={API_KEY}\"\n",
    "#     url = f\" https://rxnav.nlm.nih.gov/REST/spellingsuggestions.json?name=Nifedipine\"\n",
    "#     url = f\"https://uts-ws.nlm.nih.gov/rest/search/current?string=Candesartan cilexetil (Atacand) 8 mg&apiKey={API_KEY}\"\n",
    "#     url = f\"https://uts-ws.nlm.nih.gov/rest/content/current/CUI/C0024121?apiKey={API_KEY}\"\n",
    "#     url = f\"https://uts-ws.nlm.nih.gov/rest/content/2023AA/CUI/C0024121/definitions?apiKey={API_KEY}\"\n",
    "    url = f\"https://uts-ws.nlm.nih.gov/rest/search/current?string={term}&apiKey={API_KEY}\"\n",
    "#     url = f\"https://uts-ws.nlm.nih.gov/rest/content/current/CUI/C4277543/relations?apiKey={API_KEY}\"\n",
    "    # Send GET request\n",
    "    response = requests.get(url, headers={\"Content-Type\": \"application/json\", \"Accept\": \"application/json\", \"apikey\": API_KEY})\n",
    "\n",
    "    # Check the response status\n",
    "    if response.status_code == 200:\n",
    "        data = response.json()\n",
    "        print(data)\n",
    "        print(\"******\")\n",
    "        return data\n",
    "    else:\n",
    "        print(f\"Error {response.status_code}: {response.text}\")\n",
    "        return None\n",
    "\n",
    "# Example usage\n",
    "\n",
    "# result = search_term(term)\n",
    "result = search_term(\"MM-302 in combination with trastuzumab\")\n",
    "# if result is not None:\n",
    "#     print(result)\n",
    "#     rootSources = set()\n",
    "\n",
    "        \n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 430,
   "id": "175112a5",
   "metadata": {},
   "outputs": [
    {
     "ename": "IndentationError",
     "evalue": "unexpected indent (Temp/ipykernel_15036/920443117.py, line 2)",
     "output_type": "error",
     "traceback": [
      "\u001b[1;36m  File \u001b[1;32m\"C:\\Users\\Mina\\AppData\\Local\\Temp/ipykernel_15036/920443117.py\"\u001b[1;36m, line \u001b[1;32m2\u001b[0m\n\u001b[1;33m    'AZD9496 Variant A',\u001b[0m\n\u001b[1;37m    ^\u001b[0m\n\u001b[1;31mIndentationError\u001b[0m\u001b[1;31m:\u001b[0m unexpected indent\n"
     ]
    }
   ],
   "source": [
    "'AZD9496 (Reference)',\n",
    " 'AZD9496 Variant A',\n",
    " 'AZD9496 Variant B',\n",
    " 'AZD9496 Variant C',\n",
    " 'AZD9496 Variant D',"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2c1d192a",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c0758a09",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "\n",
    "data[data['Intervention_Ent']]"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
